Cargando…
Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use
Medical care for patients hospitalized with COVID-19 is an evolving process. Most COVID-19 inpatients (58–95%) received empiric antibiotics to prevent the increased mortality due to ventilator-associated pneumonia and other secondary infections observed in COVID-19 patients. The expected consequence...
Autores principales: | Kullar, Ravina, Johnson, Stuart, McFarland, Lynne V., Goldstein, Ellie J. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070357/ https://www.ncbi.nlm.nih.gov/pubmed/33918619 http://dx.doi.org/10.3390/antibiotics10040408 |
Ejemplares similares
-
Lactobacillus Bacteremia and Probiotics: A Review
por: Kullar, Ravina, et al.
Publicado: (2023) -
Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?
por: McFarland, Lynne V., et al.
Publicado: (2022) -
Why 2 Studies That Used the Same Probiotic May Have Come Up With Different Outcomes
por: McFarland, Lynne V, et al.
Publicado: (2021) -
Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of Clostridioides difficile Infections
por: McFarland, Lynne V., et al.
Publicado: (2023) -
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis
por: McFarland, Lynne V., et al.
Publicado: (2018)